Matinas Biopharma Holdings Inc (MTNB)

AMEX

$0.31

Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, is focused on the discovery and development of several candidate products. The company is headquartered in Bedminster, New Jersey.

Website: https://www.matinasbiopharma.com

Sector:

Healthcare

Industry:

Biotechnology

Target: $30 (+9432.89%)

Market Cap

$2.18M

P/B Ratio

0.74

Beta (5Y)

0.70

Price Chart

Adjust inflation

Log

Valuation

Market Cap$2.18M

P/S34.81

P/B0.74

Profitability

Gross Profit (TTM)-$85K

EBITDA-$6.94M

EPS-$1.89

Growth & Risk

EPS 5Y CAGR-19.47%

FCF 5Y CAGR-17.57%

Beta (5Y)0.70

Sharpe Ratio-0.28